ArticleJournal of comparative effectiveness research2026

Transportability of the comparative effect of finerenone for the treatment of symptomatic chronic heart failure with left ventricular ejection fraction of ≥40%: insights from the FINEARTS-HF trial.

Alex J Turner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.